Su-Jae Lee Selected Research

Su-Jae Lee Research Topics

Disease

87	Neoplasms (Cancer) 05/2022 - 08/2002
19	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2008
14	Glioma (Gliomas) 01/2019 - 07/2007
11	Lung Neoplasms (Lung Cancer) 01/2016 - 11/2006
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2012 - 07/2002
10	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2015
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 03/2006
9	Carcinoma (Carcinomatosis) 04/2022 - 04/2006
9	Carcinogenesis 01/2019 - 01/2004
8	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2005
6	Brain Neoplasms (Brain Tumor) 02/2018 - 02/2006
6	Mitochondrial Diseases (Mitochondrial Disease) 10/2013 - 01/2007
5	Hypoxia (Hypoxemia) 09/2021 - 07/2007
5	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 07/2009
4	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 07/2019
3	Colonic Neoplasms (Colon Cancer) 09/2019 - 12/2009
3	Multiple Myeloma 02/2013 - 01/2007
2	Melanoma (Melanoma, Malignant) 03/2020 - 01/2019
2	Circulating Neoplastic Cells 02/2019 - 03/2018
2	Laryngeal Neoplasms (Laryngeal Cancer) 11/2012 - 07/2010
2	Leukemia 09/2011 - 01/2007
2	T-Cell Lymphoma (Lymphoma, T Cell) 05/2008 - 02/2005
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2007 - 08/2002
2	Hematologic Neoplasms (Hematological Malignancy) 05/2005 - 08/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2021
1	Squamous Cell Carcinoma of Head and Neck 03/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2022 - 06/2006
10	Arsenic Trioxide (Trisenox)FDA Link 01/2012 - 07/2002
9	p38 Mitogen-Activated Protein KinasesIBA 01/2015 - 12/2003
9	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2013 - 12/2004
8	Biological ProductsIBA 03/2020 - 02/2006
7	MicroRNAs (MicroRNA)IBA 09/2021 - 06/2009
7	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2010
6	CaspasesIBA 01/2019 - 02/2003
6	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 02/2008
6	phytosphingosineIBA 09/2017 - 02/2003
5	Small Interfering RNA (siRNA)IBA 09/2019 - 12/2004
5	SurvivinIBA 09/2019 - 11/2006
5	Phosphotransferases (Kinase)IBA 11/2008 - 12/2003
5	Sulindac (Copal)FDA LinkGeneric 09/2008 - 02/2005
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2012
4	CateninsIBA 01/2019 - 09/2012
4	Peptides (Polypeptides)IBA 02/2018 - 07/2012
4	Pharmaceutical PreparationsIBA 01/2016 - 02/2005
4	Paclitaxel (Taxol)FDA LinkGeneric 08/2015 - 09/2011
4	Cytochromes c (Cytochrome c)IBA 10/2013 - 02/2003
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2022 - 10/2017
3	Epidermal Growth Factor (EGF)IBA 01/2020 - 03/2012
3	Poly (ADP-Ribose) Polymerase-1IBA 01/2019 - 12/2004
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 10/2006
3	Protein Kinases (Protein Kinase)IBA 09/2017 - 03/2006
3	AgarIBA 02/2016 - 04/2011
3	TriterpenesIBA 10/2015 - 10/2009
3	Etoposide (VP 16)FDA LinkGeneric 08/2015 - 11/2010
3	Mitogen-Activated Protein KinasesIBA 09/2014 - 12/2003
3	2-pyroneIBA 08/2013 - 01/2012
3	5- bromo- 3- (3- hydroxyprop- 1- ynyl)- 2H- pyran- 2- oneIBA 08/2013 - 01/2012
3	Aligeron (AS 2)IBA 01/2012 - 12/2004
3	Glucose (Dextrose)FDA LinkGeneric 10/2011 - 05/2007
3	Vorinostat FDA Link 12/2009 - 03/2008
3	NF-kappa B (NF-kB)IBA 01/2008 - 11/2004
2	Therapeutic UsesIBA 04/2022 - 02/2005
2	Oxygen (Dioxygen)IBA 11/2021 - 01/2019
2	Ligases (Synthetase)IBA 11/2021 - 04/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2021 - 03/2012
2	VimentinIBA 03/2021 - 06/2016
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2019 - 01/2018
2	Hyaluronic Acid (Hyaluronan)IBA 07/2019 - 01/2017
2	CytokinesIBA 06/2019 - 02/2016
2	GoldIBA 01/2019 - 01/2017
2	AMP-Activated Protein KinasesIBA 11/2018 - 02/2008
2	src-Family KinasesIBA 01/2018 - 01/2015
2	LigandsIBA 01/2018 - 07/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 11/2010
2	PhloroglucinolIBA 08/2015 - 01/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 01/2007
2	Hypoxia-Inducible Factor 1IBA 11/2014 - 07/2007
2	SuspensionsIBA 12/2013 - 06/2011
2	NestinIBA 12/2013 - 11/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2013 - 02/2006
2	cobaltous chloride (cobalt(II)chloride)IBA 11/2012 - 07/2007
2	celastrol methyl esterIBA 09/2011 - 10/2009
2	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2011 - 02/2005
2	ClaudinsIBA 05/2011 - 01/2010
2	Claudin-1IBA 05/2011 - 01/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2008 - 01/2007
2	Caspase 8 (Caspase-8)IBA 01/2007 - 02/2003
2	SeleniumIBA 01/2007 - 10/2006
2	Penicillamine (Cuprimine)FDA Link 02/2006 - 05/2003
2	DNA (Deoxyribonucleic Acid)IBA 02/2006 - 01/2004
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2022
1	Aromatase InhibitorsIBA 05/2022
1	AntibodiesIBA 04/2022
1	Leucine-Rich Repeat ProteinsIBA 11/2021
1	Insulin-Like Growth Factor Binding Protein 3IBA 03/2021

Therapy/Procedure

21	Radiotherapy 12/2021 - 02/2005
19	Therapeutics 05/2022 - 05/2003
6	Drug Therapy (Chemotherapy) 12/2021 - 07/2007
3	Aftercare (After-Treatment) 09/2013 - 11/2010
2	Molecular Targeted Therapy 01/2016 - 01/2016